Name | Taragarestrant meglumine |
---|
Description | Taragarestrant (D-0502) meglumine is a potent, orally active and selective estrogen receptor degrader (SERD). Taragarestrant meglumine shows potent activity in various ER+ breast cancer cell lines and xenograft models[1][2]. |
---|---|
Related Catalog | |
In Vivo | Taragarestrant (D-0502) exhibits superior PK profiles suitable for clinical development[1]. |
References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical. |
Molecular Formula | C32H42Cl2FN3O7 |
---|---|
Molecular Weight | 670.60 |